NCT06375759 Subarachnoid-Subarachnoid (S-S) Bypass Versus Adhesion Lysis in Spinal Arachnoiditis and Syringomyelia
| NCT ID | NCT06375759 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Xuanwu Hospital, Beijing |
| Condition | Syringomyelia |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2024-04 |
| Primary Completion | 2025-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2024-04 with a primary completion date of 2025-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To determine whether Subarachnoid-Subarachnoid (S-S) Bypass results in better patient outcomes with fewer complications and improved quality of life compared to intradural adhesion lysis in individuals with Spinal Arachnoiditis and Syringomyelia.
Eligibility Criteria
Inclusion Criteria: * 1\) history of traumatic spinal cord injury or other infection; 2) evidence of progressive neurological deficit, and/or pain syndrome; 3) MRI showing a syringomyelia due to spinal trauma or other infection; and 4) minimum follow-up period of more than 1 year. Exclusion Criteria: * Chiari-malformation, myelomalacia, subarachnoid cyst, syringomyelia due to other spinal diseases (such as degenerative spinal disease)
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06375759 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Syringomyelia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06375759 currently recruiting?
Yes, NCT06375759 is actively recruiting participants. Contact the research team at jianfengzeng@xwh.ccmu.edu.cn for enrollment information.
Where is the NCT06375759 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT06375759 clinical trial?
NCT06375759 is sponsored by Xuanwu Hospital, Beijing. The trial plans to enroll 200 participants.